Dexcom is a medical technology company based in San Diego, California, that develops and manufactures continuous glucose monitoring (CGM) systems for diabetes management. The company was founded in 1999 by Scott Glenn, John Burd, and Terrance Gregg, and went public in 2005.
Dexcom's CGM systems are designed to help people with diabetes better manage their blood glucose levels by providing real-time glucose readings every five minutes, 24 hours a day, without the need for fingersticks. The system consists of a small sensor that is inserted under the skin and a transmitter that sends glucose data wirelessly to a compatible smart device or receiver. The data can also be shared with healthcare providers and family members through a secure online portal.
Dexcom's products have been approved for use in adults and children with diabetes, and the company is committed to advancing the use of CGM technology in healthcare. In addition to its core CGM systems, Dexcom has developed a range of products and services to help people with diabetes manage their condition, including mobile apps, educational resources, and support programs. The company also collaborates with other companies and organizations in the diabetes space to improve patient outcomes.
Dexcom's CGM systems have received widespread recognition for their effectiveness in diabetes management, and the company has received numerous awards for its innovation and product quality. Dexcom is also committed to driving access to CGM technology through partnerships with insurers and healthcare providers, and has established relationships with a range of organizations to expand patient access to its products.
As of 2021, Dexcom is one of the leading providers of CGM systems worldwide, with a presence in more than 50 countries. The company has continued to innovate and develop new products and services to help people with diabetes manage their condition, and is committed to improving patient outcomes and advancing the use of CGM technology in healthcare.